Effects of oligofructose containing diet in obese persons;Az oligofruktóz hatásának vizsgálata elhízottakban

Orvosi Hetilap

Volumn 149, Issue 42, 2008, Pages 1989-1995

  Antal, Magda ^a,c   Regöly Mérei, Andrea ^a   Biró, Lajos ^a   Arató, Györgyi ^a   Schmidt, Judit ^a   Nagy, Katalin ^a   Greiner, Erika ^a   Lásztity, Natália ^b   Szabó, Csaba ^a   Péter, Szabolcs ^a   Martos, Éva ^a  

^a Orszagos Gyogyszereszeti Intezet   (Hungary)

^b Fovarosi Heim Pal Gyermekkórház Rendelointézet Haematológiai   (Hungary)

^c NONE   (Hungary)

Author keywords

Adolescents; Adults; Obesity; Oligofructose

Indexed keywords

ADIPOCYTOKINE; FRUCTOSE OLIGOSACCHARIDE; LIPID; TRIACYLGLYCEROL;

ADOLESCENT; ADULT; ANTHROPOMETRY; ARTICLE; BODY FAT; BODY MASS; CARBOHYDRATE METABOLISM; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUNGER; INSULIN RESISTANCE; JERUSALEM ARTICHOKE; LIPID BLOOD LEVEL; LOW CALORY DIET; MALE; OBESITY; PILOT STUDY; THERAPY EFFECT; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 55749115061     PISSN: 00306002     EISSN: 17886120     Source Type: Journal    
DOI: 10.1556/OH.2008.28387     Document Type: Article

References (30)

1. Roberfroid, M. B., Delzenne N. M.: Dietary fructans. Ann. Rev. Nutr., 1998, 18, 117-143.
2. Krause's Food, Nutrition, Diet Therapy. Szerk.: Mahan K. L., Escott-Stumps S. 1996, WB Saunders Co., 42, 47.
3. Crow, D.: Inulin - a comprehensive scientific review. 2000, http://members.shaw.ca/duncancrow/inulin_review.html
4. Antal M.: A fruktánok táplálkozás-élettani megítélése. Sport és Egészségtudomány, 2004, 3 (Suppl. 1.), 14-17.
5. Report of Joint WHO/FAO expert Consultation: Diet, nutrition and the prevention of chronic diseases. WHO Tech. Rep. Ser. 916, Geneva, 2003, 77, 88.
6. Fehér J., Lengyel G.: Táplálkozás és a szív- és érrendszeri betegségek miatti halálozás. Orv. Hetil., 2006, 147, 1491-1496.
7. Fehér J., Lengyel G.: Roziglitazon é glimepirid kombinációs készítmény alkalmazása 2-es típusú diabetes mellitus kezelésében. Orv. Hetil., 2007, 148, 2331-2335.
8. Pados G.: Az elhízás kezelése. Orv. Hetil., 2004, 145, 1765-1767.
9. Juhász A., Katona E., Csongrádi É. é mtsa: Az elhízásról - a gyakorló orvos szemszögébol. Orv. Hetil., 2006, 147, 579-590.
10. Kalavainen, M. P., Karppi, M. O., Nuutinen, O. M.: Clinical efficacy of group-based treatment for childhood obesity compared with routinely given individual counseling. Int. J. Obesity, 2007, 31, 1500-1508.
11. WHO: Physical status, the use and interpretation of anthropometry. WHO Tech. Rep. Ser. 854, Geneva, 1995, 263-311, 445.
12. Antal, M., Biró, L., Regöly-Mérei, A. és mtsai: Az epidemiológiai vizsgálatokban alkalmazható néhány méromódszer a serdülokori elhízás megítélésére. Orv. Hetil., 2008, 149, 51-57.
13. Monzillo, L. U., Hamdy, O.: Evaluation of insulin sensitivity in clinical practice and in research settings. Nutr. Rev., 2003, 61, 397-412.
14. Dhuper, S., Cohen, H. W., Daniel, J. és mtsai: Utility of modified ATP III defined metabolic syndrome and severe obesity as predictors of insulin resistance in overweight children and adolescents: a cross-sectional study. Cardiovasc. Diabetol., 2007, 6, 1186-1195.
15. Strasser, B., Spreitzer, A., Haber, P.: Fat loss depends on energy deficit only, independently of the method for weight loss. Ann. Nutr. Metab., 2007, 51, 428-432.
16. Ditschuneit, H. H., Frier, H. I., Flechtner-Mors, M.: Lipoprotein responses to weight loss and weight maintenance in high-risk obese subjects. Eur. J. Clin. Nutr., 2002, 56, 264-270.
17. Assmann, G., Schulte, H., Funke, H. és mtsai: The emergency of triglicerides as a significant independent risk factor in coronary artery disease. Eur. Heart J., 1998, 19, M8-M14.
18. Asia Pacific Cobort Studies Collaboration: Serum triglycerides as a risk factor for cardiovascular diseases in the Asia-Pacific Region. Circulation, 2004, 110, 2678-2686.
19. Luo, J., Rizkalla, S. W., Alamowitch, C. és mtsai: Chronic consumption of short-chain fructooligosaccharides by healthy subjects decreased basal hepatic glucose production but had no effect on insulin-stimulated glucose metabolism. Am. J. Clin. Nutr., 1996, 63, 939-945.
20. Pedersen, A., Sandstrom, B., Van Amelspoort, J. M. M.: The effect of ingestion of mulin on blood lipids and gastrointestinal symptoms in healthy females. Br. J. Nutr., 1997, 78, 215-222.
21. Jackson, K. G., Taylor, G. R. J., Clohessy, A. M. és mtsa: The effect of the daily intake of inulin on fasting lipid, insulin and glucose concentrations in middle aged men and women. Br. J. Nutr., 1999, 82, 23-30.
22. Letexier, D., Diraison, F., Beylot, M.: Addition of inutin to moderately high-carbohydrate diet reduces hepatic lipogenesis and plasma triacylglycerol concentrations in humans. Am. J. Clin. Nutr., 2003, 77, 559-564.
23. Roberfroid, M. B.: Prebiotics and probiotics: are they functional foods? Am. J. Clin. Nutr., 2000, 71, 1682S-1687S.
24. Delzenne, N. M., Daubioul, C., Neyrinck, A. és mtsai: Inulin and oligofructose modulate lipid metabolism in animals: review of biochemical events and future prospects, Br. J. Nutr., 2002, 87, S255-S259.
25. Williams, C. M.: Effects of inulin on lipid parameters in humans. J. Nutr., 1999, 129, 1471S-1473S.
26. Balcázar-Muñoz, B. R., Martínez-Abundis E., Gonzáles-Ortiz, M.: Effect of oral inulin administration on lipid profile and insulin sensitivity in subjects with obesity and dyslipidemia. Rev. Med. Chil., 2003, 131, 597-604.
27. Yamashita, K., Kawai, K., Itakura, J.: Effects of fructo-oligosac-charides on blood glucose and serum lipids in diabetic subjects. Nutr. Res., 1984, 4, 961-966.
28. Alles, M. S., de Roos, N. M., Bakx, J. C. és mtsai: Consumption of fructooligosaccharides does not favourably affect blood glucose and serum lipid concentration in patients with type II diabetes. Am. J. Clin. Nutr., 1999, 69, 64-69.
29. Ahima, R. S., Lazar, M. A.: Adipokines and the peripheral and neural control of energy balance. Mol. Edocrinol., 2008, jan 17, doi:10./ me.2007-0529.
30. Valsamakis, G., McTernan, P. G., Chetty, R. és mtsai: Modest weight loss and reduction in waist circumference after medical treatment are associated with favorable changes in serum adipocytokines. Metabolism, 2004, 53, 430-434.